NeuroOne Medical Technologies Corporation

US$0.88As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NMTCHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (37.18%)
Div yield —
ROE (124.66%)
Medical Devices
Beta (5Y) 0.90
PE TTM —
TSR TTM (81.50%)
Mkt cap US$8.004M
ROIC (79.53%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.903
2.70%
(76.81%)
Hold 11|8|7|5|9
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.01
0.01
0.01
0.01
7.24%
1.66%
0.18%
(4.11%)
Revenue$M
0.383
0.373
0.378
0.387
9.19%
4.76%
3.76%
1.26%
Peers (US$8.004M)
Cap (US$)
PE
7.404M
—
5.964M
—
8.134M
—
Capital
TTM
5Y
10Y
Leveragex
0.558
1.020
0.648
EBIT/Intx
0.210
0.190
0.152
Own earn%
(52.79)
(180.17)
(160.74)
Sh yield%
25.92
49.17
48.32
Owners
Insiders/Inst%
1.37
77.41
Short interest%
1.16
SBC / revenue%
1.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
14–18
$1 testx
—
Incr. ROIC%
6